{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:33:52Z","timestamp":1791920032895,"version":"4.3.4"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI070791-03S1"],"award-info":[{"award-number":["AI070791-03S1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01-AI082068"],"award-info":[{"award-number":["U01-AI082068"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21AI109185"],"award-info":[{"award-number":["R21AI109185"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["U54 AI057159"],"award-info":[{"award-number":["U54 AI057159"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Biomedical Graduate Research Organization of Georgetown University"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.antiviral.2016.08.014","type":"journal-article","created":{"date-parts":[[2016,8,15]],"date-time":"2016-08-15T16:32:52Z","timestamp":1471278772000},"page":"6-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["High-throughput screening for the identification of small-molecule inhibitors of the flaviviral protease"],"prefix":"10.1016","volume":"134","author":[{"given":"Anuradha","family":"Balasubramanian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Manzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadahisa","family":"Teramoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajendra","family":"Pilankatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radhakrishnan","family":"Padmanabhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2016.08.014_bib1","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1099\/vir.0.024083-0","article-title":"Construction of a dengue virus type 4 reporter replicon and analysis of temperature-sensitive mutations in non-structural proteins 3 and 5","volume":"91","author":"Alcaraz-Estrada","year":"2010","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.antiviral.2016.08.014_bib2","series-title":"Methods Mol Biol, 2013\/07\/04 Ed","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/978-1-62703-484-5_22","article-title":"Construction of self-replicating subgenomic West Nile virus replicons for screening antiviral compounds","author":"Alcaraz-Estrada","year":"2013"},{"key":"10.1016\/j.antiviral.2016.08.014_bib3","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1110\/ps.072753207","article-title":"Structural evidence for regulation and specificity of flaviviral proteases and evolution of the Flaviviridae fold","volume":"16","author":"Aleshin","year":"2007","journal-title":"Protein Sci."},{"key":"10.1016\/j.antiviral.2016.08.014_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/NDT.S2404","article-title":"COMT inhibition with tolcapone in the treatment algorithm of patients with Parkinson's disease (PD): relevance for motor and non-motor features","volume":"4","author":"Antonini","year":"2008","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.antiviral.2016.08.014_bib5","doi-asserted-by":"crossref","first-page":"835","DOI":"10.2174\/156652405774962272","article-title":"Recent advances in the molecular biology of west nile virus","volume":"5","author":"Beasley","year":"2005","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.antiviral.2016.08.014_bib6","doi-asserted-by":"crossref","first-page":"W252","DOI":"10.1093\/nar\/gku340","article-title":"SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information","volume":"42","author":"Biasini","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.antiviral.2016.08.014_bib7","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ab.2009.08.013","article-title":"A\u00a0fluorescence quenching assay to discriminate between specific and nonspecific inhibitors of dengue virus protease","volume":"395","author":"Bodenreider","year":"2009","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.antiviral.2016.08.014_bib8","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.antiviral.2014.03.014","article-title":"Amodiaquine, an antimalarial drug, inhibits dengue virus type 2 replication and infectivity","volume":"106","author":"Boonyasuppayakorn","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.08.014_bib9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1517\/14740338.4.1.69","article-title":"Tolcapone in Parkinson's disease: liver toxicity and clinical efficacy","volume":"4","author":"Borges","year":"2005","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.antiviral.2016.08.014_bib10","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.2174\/138955708786140990","article-title":"Antimicrobial and antiviral activity of hydrolysable tannins","volume":"8","author":"Buzzini","year":"2008","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.antiviral.2016.08.014_bib11","doi-asserted-by":"crossref","first-page":"6797","DOI":"10.1128\/JVI.67.11.6797-6807.1993","article-title":"Mutagenesis of the yellow fever virus NS2B protein: effects on proteolytic processing, NS2B-NS3 complex formation, and viral replication","volume":"67","author":"Chambers","year":"1993","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.08.014_bib12","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1128\/JVI.69.3.1600-1605.1995","article-title":"Mutagenesis of the yellow fever virus NS2B\/3 cleavage site: determinants of cleavage site specificity and effects on polyprotein processing and viral replication","volume":"69","author":"Chambers","year":"1995","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.08.014_bib13","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1128\/JVI.02044-09","article-title":"Serotype-specific structural differences in the protease-cofactor complexes of the dengue virus family","volume":"84","author":"Chandramouli","year":"2010","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.08.014_bib14","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1042\/BJ20091645","article-title":"Identification of broad-based HIV-1 protease inhibitors from combinatorial libraries","volume":"429","author":"Chang","year":"2010","journal-title":"Biochem. J."},{"key":"10.1016\/j.antiviral.2016.08.014_bib15","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0278-6915(98)00086-6","article-title":"Mechanism of inhibition of tannic acid and related compounds on the growth of intestinal bacteria","volume":"36","author":"Chung","year":"1998","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.antiviral.2016.08.014_bib16","doi-asserted-by":"crossref","first-page":"30715","DOI":"10.1074\/jbc.272.49.30715","article-title":"Cotranslational membrane insertion of the serine proteinase precursor NS2B-NS3(Pro) of dengue virus type 2 is required for efficient in\u00a0vitro processing and is mediated through the hydrophobic regions of NS2B","volume":"272","author":"Clum","year":"1997","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.antiviral.2016.08.014_bib17","first-page":"880","article-title":"The rise and fall of tolcapone","volume":"246","author":"Colosimo","year":"1999","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.antiviral.2016.08.014_bib18","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nsmb1073","article-title":"Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus","volume":"13","author":"Erbel","year":"2006","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.antiviral.2016.08.014_bib19","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.antiviral.2012.02.003","article-title":"Characterization of the 8-hydroxyquinoline scaffold for inhibitors of West Nile virus serine protease","volume":"94","author":"Ezgimen","year":"2012","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.08.014_bib20","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1016\/j.bmc.2009.03.050","article-title":"Effects of detergents on the West Nile virus protease activity","volume":"17","author":"Ezgimen","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.antiviral.2016.08.014_bib21","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1128\/JVI.67.4.2034-2042.1993","article-title":"Deletion analysis of dengue virus type 4 nonstructural protein NS2B: identification of a domain required for NS2B-NS3 protease activity","volume":"67","author":"Falgout","year":"1993","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.08.014_bib22","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/nchembio718","article-title":"High-throughput assays for promiscuous inhibitors","volume":"1","author":"Feng","year":"2005","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.antiviral.2016.08.014_bib23","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nprot.2006.77","article-title":"A\u00a0detergent-based assay for the detection of promiscuous inhibitors","volume":"1","author":"Feng","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.antiviral.2016.08.014_bib24","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/nrd1907","article-title":"Tipranavir","volume":"4","author":"Flexner","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.antiviral.2016.08.014_bib25","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0140-6736(08)60238-X","article-title":"Pathogenic flaviviruses","volume":"371","author":"Gould","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2016.08.014_bib26","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1038\/nrmicro2460","article-title":"Dengue: a continuing global threat","volume":"8","author":"Guzman","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.antiviral.2016.08.014_bib27","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.vaccine.2004.03.069","article-title":"Dengue virus: molecular basis of cell entry and pathogenesis, 25-27 June 2003, Vienna, Austria","volume":"23","author":"Halstead","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2016.08.014_bib28","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1128\/CMR.3.4.376","article-title":"The dengue viruses","volume":"3","author":"Henchal","year":"1990","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.antiviral.2016.08.014_bib29","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.2165\/00003495-200059060-00004","article-title":"Clinical pharmacology, therapeutic use and potential of COMT inhibitors in Parkinson's disease","volume":"59","author":"Kaakkola","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.antiviral.2016.08.014_bib30","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0022-3476(97)70054-4","article-title":"Dengue virus infection: epidemiology, pathogenesis, clinical presentation, diagnosis, and prevention","volume":"131","author":"Kautner","year":"1997","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.antiviral.2016.08.014_bib31","doi-asserted-by":"crossref","first-page":"12891","DOI":"10.1074\/jbc.M112.442723","article-title":"NMR analysis of a novel enzymatically active unlinked dengue NS2B-NS3 protease complex","volume":"288","author":"Kim","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.antiviral.2016.08.014_bib32","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.antiviral.2012.10.009","article-title":"Characterization of 8-hydroxyquinoline derivatives containing aminobenzothiazole as inhibitors of dengue virus type 2 protease in\u00a0vitro","volume":"97","author":"Lai","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.08.014_bib33","first-page":"345","article-title":"Construction of dengue virus protease expression plasmid and in\u00a0vitro protease assay for screening antiviral inhibitors","author":"Lai","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.antiviral.2016.08.014_bib34","doi-asserted-by":"crossref","first-page":"45762","DOI":"10.1074\/jbc.M107360200","article-title":"Activity of recombinant dengue 2 virus NS3 protease in the presence of a truncated NS2B co-factor, small peptide substrates, and inhibitors","volume":"276","author":"Leung","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.antiviral.2016.08.014_bib35","doi-asserted-by":"crossref","first-page":"28766","DOI":"10.1074\/jbc.M500588200","article-title":"Functional profiling of recombinant NS3 proteases from all four serotypes of dengue virus using tetrapeptide and octapeptide substrate libraries","volume":"280","author":"Li","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.antiviral.2016.08.014_bib36","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.antiviral.2013.09.013","article-title":"Ten years of dengue drug discovery: progress and prospects","volume":"100","author":"Lim","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.08.014_bib37","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/1471-2180-13-187","article-title":"Broad-spectrum antiviral activity of chebulagic acid and punicalagin against viruses that use glycosaminoglycans for entry","volume":"13","author":"Lin","year":"2013","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.antiviral.2016.08.014_bib38","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0065-3527(03)59002-9","article-title":"Molecular biology of flaviviruses","volume":"59","author":"Lindenbach","year":"2003","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.antiviral.2016.08.014_bib39","series-title":"Field's Virology","first-page":"1101","article-title":"Flaviviridae: the viruses and their replication","author":"Lindenbach","year":"2007"},{"key":"10.1016\/j.antiviral.2016.08.014_bib40","doi-asserted-by":"crossref","first-page":"22521","DOI":"10.1074\/jbc.M111.234302","article-title":"Identification of cis-acting elements in the 3'-untranslated region of the dengue virus type 2 RNA that modulate translation and replication","volume":"286","author":"Manzano","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.antiviral.2016.08.014_bib41","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1099\/0022-1317-82-7-1647","article-title":"Mutagenesis of the dengue virus type 2 NS3 proteinase and the production of growth-restricted virus","volume":"82","author":"Matusan","year":"2001","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.antiviral.2016.08.014_bib42","doi-asserted-by":"crossref","first-page":"8873","DOI":"10.1074\/jbc.M609919200","article-title":"The non-structural protein 4A of dengue virus is an integral membrane protein inducing membrane alterations in a 2K-regulated manner","volume":"282","author":"Miller","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.antiviral.2016.08.014_bib43","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1001\/jama.2013.4903","article-title":"Dengue more prevalent than previously thought","volume":"309","author":"Mitka","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.antiviral.2016.08.014_bib44","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1128\/AAC.01508-07","article-title":"Identification and biochemical characterization of small-molecule inhibitors of west nile virus serine protease by a high-throughput screen","volume":"52","author":"Mueller","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2016.08.014_bib45","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.biocel.2006.10.025","article-title":"Characterization of the West Nile virus protease substrate specificity and inhibitors","volume":"39","author":"Mueller","year":"2007","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.antiviral.2016.08.014_bib46","doi-asserted-by":"crossref","first-page":"48535","DOI":"10.1074\/jbc.M406810200","article-title":"Enzymatic characterization and homology model of a catalytically active recombinant West Nile virus NS3 protease","volume":"279","author":"Nall","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.antiviral.2016.08.014_bib47","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.antiviral.2009.12.011","article-title":"Strategies for development of dengue virus inhibitors","volume":"85","author":"Noble","year":"2010","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.08.014_bib48","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1128\/JVI.06225-11","article-title":"Ligand-bound structures of the dengue virus protease reveal the active conformation","volume":"86","author":"Noble","year":"2012","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.08.014_bib49","series-title":"Frontiers in Dengue Virus Research","first-page":"14","article-title":"Translation and processing of the dengue virus polyprotein","author":"Padmanabhan","year":"2010"},{"key":"10.1016\/j.antiviral.2016.08.014_bib50","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1128\/CMR.11.4.614","article-title":"Protease inhibitors as antiviral agents","volume":"11","author":"Patick","year":"1998","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.antiviral.2016.08.014_bib51","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S1473-3099(12)70060-9","article-title":"Protease inhibitors for the treatment of chronic hepatitis C genotype-1 infection: the new standard of care","volume":"12","author":"Pearlman","year":"2012","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.08.014_bib52","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1128\/AAC.50.4.1320-1329.2006","article-title":"Triaryl pyrazoline compound inhibits flavivirus RNA replication","volume":"50","author":"Puig-Basagoiti","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2016.08.014_bib53","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.antiviral.2008.08.004","article-title":"Molecular targets for flavivirus drug discovery","volume":"81","author":"Sampath","year":"2009","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.08.014_bib54","doi-asserted-by":"crossref","first-page":"W363","DOI":"10.1093\/nar\/gki481","article-title":"PatchDock and SymmDock: servers for rigid and symmetric docking","volume":"33","author":"Schneidman-Duhovny","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.antiviral.2016.08.014_bib55","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.cellimm.2010.02.005","article-title":"Secondary heterologous dengue infection risk: disequilibrium between immune regulation and inflammation?","volume":"262","author":"Sierra","year":"2010","journal-title":"Cell Immunol."},{"key":"10.1016\/j.antiviral.2016.08.014_bib56","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1096\/fj.03-0093life","article-title":"The discovery of captopril","volume":"17","author":"Smith","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.antiviral.2016.08.014_bib57","doi-asserted-by":"crossref","first-page":"e88062","DOI":"10.1371\/journal.pone.0088062","article-title":"Tannins from Hamamelis virginiana bark extract: characterization and improvement of the antiviral efficacy against influenza A virus and human papillomavirus","volume":"9","author":"Theisen","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.antiviral.2016.08.014_bib58","doi-asserted-by":"crossref","first-page":"e55343","DOI":"10.1371\/journal.pone.0055343","article-title":"Inactivation of pathogenic viruses by plant-derived tannins: strong effects of extracts from persimmon (Diospyros kaki) on a broad range of viruses","volume":"8","author":"Ueda","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.antiviral.2016.08.014_bib59","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0307-4412(00)00029-7","article-title":"Enzyme kinetics: partial and complete uncompetitive inhibition","volume":"28","author":"Whiteley","year":"2000","journal-title":"Biochem. Educ."},{"key":"10.1016\/j.antiviral.2016.08.014_bib60","doi-asserted-by":"crossref","first-page":"878","DOI":"10.3390\/12040878","article-title":"How many drugs are catecholics","volume":"12","author":"Yang","year":"2007","journal-title":"Molecules"},{"key":"10.1016\/j.antiviral.2016.08.014_bib61","doi-asserted-by":"crossref","first-page":"27412","DOI":"10.1074\/jbc.M501393200","article-title":"Modulation of the nucleoside triphosphatase\/RNA helicase and 5'-RNA triphosphatase activities of dengue virus type 2 nonstructural protein 3 (NS3) by interaction with NS5, the RNA-dependent RNA polymerase","volume":"280","author":"Yon","year":"2005","journal-title":"J.\u00a0Biol. Chem."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216302819?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216302819?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T05:31:48Z","timestamp":1601011908000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354216302819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":61,"alternative-id":["S0166354216302819"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.08.014","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-throughput screening for the identification of small-molecule inhibitors of the flaviviral protease","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}